Constarium
← Search

Omics · study · 2026

Pembrolizumab with or without vorinostat in first-line metastatic non-small cell lung cancer: a randomized phase 2 trial

Listed in NCBI GEO

Bulk RNA sequencing was performed on fresh-frozen tumor biopsies collected from patients with treatment-naïve metastatic non-small cell lung cancer (NSCLC) enrolled in a randomized phase II clinical trial comparing pembrolizumab monotherapy with pembrolizumab plus the histone deacetylase inhibitor vorinostat.

Description

Tumor biopsies were obtained before treatment and during cycle 1 (days 14–21) to characterize treatment-induced transcriptional changes associated with PD-1 blockade alone or in combination with HDAC inhibition.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34357012 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title